GlassScriptPhysician profile
Bruce R Brady
NPI 1467474676
$5,123.54
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,016 · 2020: $1,426 · 2021: $1,497 · 2022: $184.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $498.31 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $486.00 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.61 | 2019-2022 | |
| Novo Nordisk INC | $413.50 | 2019-2021 | |
| Antares Pharma, INC. | $355.43 | 2019-2022 | |
| Abbott Laboratories | $349.34 | 2019-2022 | |
| Abbvie INC. | $289.77 | 2019-2022 | |
| Lilly USA, LLC | $237.28 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $211.74 | 2020-2021 | |
| Radius Health, INC. | $199.97 | 2019-2021 | |
| Insulet Corporation | $181.03 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $175.94 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $169.70 | 2019 | |
| Corcept Therapeutics | $154.25 | 2020-2021 | |
| Medtronic Minimed, INC. | $138.49 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2021 | |
| Dexcom, INC. | $122.42 | 2019-2022 | |
| Amgen INC. | $108.85 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $76.54 | 2020-2021 | |
| Amarin Pharma, INC. | $70.26 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $59.29 | 2019 | |
| Mannkind Corporation | $42.91 | 2020-2021 | |
| Vistapharm, INC. | $42.90 | 2021 | |
| Lifescan, INC. | $29.88 | 2019 | |
| Medtronic, INC. | $25.26 | 2021 | |
| Amryt Pharma Holdings LTD | $19.04 | 2021 | |
| Ibsa Pharma INC. | $18.75 | 2020 | |
| Alexion Pharmaceuticals, INC. | $16.98 | 2020 | |
| Becton, Dickinson and Company | $16.82 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $14.81 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.63 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $13.56 | 2021 | |
| Zealand Pharma US, INC. | $11.28 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.